Contract facts
UnrestrictedBAA Research Area 004: Development of in Vitro Diagnostics for Biodefense, Antimicrobial Resistant Infections (AMR), an… is a federal Unrestricted award for National Institutes Of Health Niaid held by Siemens Healthcare Diagnostics Inc. Estimated value $5.4M ($5.4M obligated). Current period of performance ends Dec 31, 2026. Last award drew 19 bidders. Place of performance: TARRYTOWN NY. Related solicitation BAA2022-1.
Baa research area 004: development of in vitro diagnostics for biodefense, antimicrobial resistant infections (amr), and emerging infectious diseases. Latest action is a modification.
Recompete timing
PublicCurrent PoP ends Dec 31, 2026 (75 days remaining). Agencies typically plan 12–18 months ahead — at 2.5 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 75N93023C00025? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordSiemens Healthcare Diagnostics Inc — $112.7M obligated across 924 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 75N93023C00025?
75N93023C00025 (AMR BAA research area 004) is a National Institutes Of Health Niaid award with a potential value of $5.4M, currently held by Siemens Healthcare Diagnostics Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 75N93023C00025?
National Institutes Of Health Niaid awarded 75N93023C00025 to Siemens Healthcare Diagnostics Inc (potential $5.4M).
Who is the incumbent on 75N93023C00025?
Siemens Healthcare Diagnostics Inc is the incumbent with $112.7M across 924 related awards in SCOUT’s public footprint. The current period of performance ends Dec 31, 2026.
When does Siemens Healthcare Diagnostics Inc’s 75N93023C00025 come up for recompete?
SCOUT tracks a period-of-performance end of Dec 31, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 75N93023C00025? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.